华芢生物-B(02396):稳定价格期间结束、无稳定价格行动及超额配股权失效

智通财经
Jan 18

智通财经APP讯,华芢生物-B(02396)发布公告,有关全球发售的稳定价格期间已于2026年1月16日(星期五)(即递交香港公开发售申请截止日期后第30日)结束。

国际发售项下的发售股份并无超额分配。因此,超额配股权并未获行使,且超额配股权已于2026年1月16日(星期五)失效。本公司获稳定价格操作人告知,稳定价格操作人(或任何代其行事的人士)于稳定价格期间并无采取稳定价格行动。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10